ALGETA Aktie

18,61 EUR -1,3259%

Zu Ihrem Onlinebroker

kaufen verkaufen

ALGETA Aktienkurs : 23.05. ( 15 Min. verzögert)
18,61 € Letzter Kurs	-1,33% Veränderung	18,86 € Vortag	18,86 € Eröffnungskurs

Realtime:

18,61

-1,33%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
18,86 - 18,61 Tag	28,22 - 16,43 52 Wochen	0 Tag	10 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

ALGETA Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

17.05.

Updated survival results from phase III trial of radium-223 chloride in ...

Oslo, Norway, 16 May 2012 - Algeta ASA (OSE: ALGETA) announces that further data from the phase III ALSYMPCA study of radium-223 chloride will be presented in...
16.05.

ALGETA ASA : Updated survival results from phase III trial of Alpharadin ...

Oslo, Norway, 16 May 2012 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that further data from the...

14.05.

Algeta to Present at Forthcoming Life Sciences Investor Conferences

Not intended for US media Oslo, Norway, 14 May 2012 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior...
07.05.

Tang Capital's Holdings: Insights Into Successful Investing

... the valuation of other companies developing promising prostate cancer drugs including Medivation (MDVN), which has an EV of $2.77 billion and Algeta (ALGETA.OL), which has an EV of approximately $974 million.
07.05.

Tang Capital's Holdings: Insights Into Successful Investing

... the valuation of other companies developing promising prostate cancer drugs including Medivation (MDVN), which has an EV of $2.77 billion and Algeta (ALGETA.OL), which has an EV of approximately $974 million.